• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

啮齿动物和人类对新型隐球菌蛋白的抗体反应。

Antibody response to Cryptococcus neoformans proteins in rodents and humans.

作者信息

Chen L C, Goldman D L, Doering T L, Pirofski L a, Casadevall A

机构信息

Department of Microbiology and Immunology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461-2187, USA.

出版信息

Infect Immun. 1999 May;67(5):2218-24. doi: 10.1128/IAI.67.5.2218-2224.1999.

DOI:10.1128/IAI.67.5.2218-2224.1999
PMID:10225877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC115960/
Abstract

The prevalence and specificity of serum antibodies to Cryptococcus neoformans proteins was studied in mice and rats with experimental infection, in individuals with or without a history of potential laboratory exposure to C. neoformans, human immunodeficiency virus (HIV)-positive individuals who developed cryptococcosis, in matched samples from HIV-positive individuals who did not develop cryptococcosis, and in HIV-negative individuals. Rodents had little or no serum antibody reactive with C. neoformans proteins prior to infection. The intensity and specificity of the rodent antibody response were dependent on the species, the mouse strain, and the viability of the inoculum. All humans had serum antibodies reactive with C. neoformans proteins regardless of the potential exposure, the HIV infection status, or the subsequent development of cryptococcosis. Our results indicate (i) a high prevalence of antibodies reactive with C. neoformans proteins in the sera of rodents after cryptococcal infection and in humans with or without HIV infection; (ii) qualitative and quantitative differences in the antibody profiles of HIV-positive individuals; and (iii) similarities and differences between humans, mice, and rats with respect to the specificity of the antibodies reactive with C. neoformans proteins. The results are consistent with the view that C. neoformans infections are common in human populations, and the results have implications for the development of vaccination strategies against cryptococcosis.

摘要

在患有实验性感染的小鼠和大鼠、有或无潜在实验室接触新型隐球菌病史的个体、发生隐球菌病的人类免疫缺陷病毒(HIV)阳性个体、未发生隐球菌病的HIV阳性个体的匹配样本以及HIV阴性个体中,研究了血清中针对新型隐球菌蛋白的抗体的患病率和特异性。在感染前,啮齿动物几乎没有或没有与新型隐球菌蛋白发生反应的血清抗体。啮齿动物抗体反应的强度和特异性取决于物种、小鼠品系以及接种物的活力。无论有无潜在接触、HIV感染状态或随后是否发生隐球菌病,所有人类都有与新型隐球菌蛋白发生反应的血清抗体。我们的结果表明:(i)新型隐球菌感染后,啮齿动物血清以及有或无HIV感染的人类血清中与新型隐球菌蛋白发生反应的抗体患病率很高;(ii)HIV阳性个体的抗体谱存在定性和定量差异;(iii)在与新型隐球菌蛋白发生反应的抗体特异性方面,人类、小鼠和大鼠之间存在异同。这些结果与新型隐球菌感染在人群中很常见的观点一致,并且这些结果对开发针对隐球菌病的疫苗策略具有启示意义。

相似文献

1
Antibody response to Cryptococcus neoformans proteins in rodents and humans.啮齿动物和人类对新型隐球菌蛋白的抗体反应。
Infect Immun. 1999 May;67(5):2218-24. doi: 10.1128/IAI.67.5.2218-2224.1999.
2
Serologic evidence for Cryptococcus neoformans infection in early childhood.儿童期早期新型隐球菌感染的血清学证据。
Pediatrics. 2001 May;107(5):E66. doi: 10.1542/peds.107.5.e66.
3
A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.一种基于蛋白质组学的方法用于鉴定新型隐球菌免疫显性蛋白。
Proteomics. 2009 May;9(9):2578-88. doi: 10.1002/pmic.200800713.
4
Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.乌干达感染和未感染人类免疫缺陷病毒人群的新型隐球菌反应性及总免疫球蛋白谱
Clin Diagn Lab Immunol. 2005 Oct;12(10):1168-76. doi: 10.1128/CDLI.12.10.1168-1176.2005.
5
Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.通过免疫印迹法分析5例艾滋病合并隐球菌病患者对新型隐球菌的抗体反应。
J Infect. 2000 Jan;40(1):64-8. doi: 10.1053/jinf.1999.0592.
6
Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.与隐球菌荚膜多糖葡糖醛酸木糖甘露聚糖反应的抗体存在于感染和未感染人类免疫缺陷病毒的儿童血清中。
J Infect Dis. 1999 Sep;180(3):915-9. doi: 10.1086/314953.
7
Vaccination with Recombinant Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.葡聚糖颗粒中的重组蛋白疫苗以依赖于小鼠品系和隐球菌种属的方式保护小鼠免受隐球菌病的侵害。
mBio. 2017 Nov 28;8(6):e01872-17. doi: 10.1128/mBio.01872-17.
8
Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.鉴定与新型隐球菌性脑膜炎患者血清 IgG 反应的疾病相关隐球菌蛋白。
Front Immunol. 2021 Jul 23;12:709695. doi: 10.3389/fimmu.2021.709695. eCollection 2021.
9
Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.印度隐球菌病患者对新型隐球菌的抗体反应。
Med Mycol. 2008 Aug;46(5):457-63. doi: 10.1080/13693780801961345. Epub 2008 Mar 10.
10
Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.热休克蛋白70(hsp70)作为肺隐球菌病患者抗体反应的主要靶点。
Clin Exp Immunol. 1999 Mar;115(3):485-90. doi: 10.1046/j.1365-2249.1999.00821.x.

引用本文的文献

1
Active Cryptococcus neoformans glucuronoxylomannan production prevents elimination of cryptococcal CNS infection in vivo.新型隐球菌活性葡糖醛酸木聚糖甘露聚糖的产生可阻止体内隐球菌中枢神经系统感染的清除。
J Neuroinflammation. 2025 Mar 4;22(1):61. doi: 10.1186/s12974-025-03384-9.
2
Ex Vivo Host Transcriptomics During Cryptococcus neoformans, Cryptococcus gattii, and Candida albicans Infection of Peripheral Blood Mononuclear Cells From South African Volunteers.南非志愿者外周血单核细胞受新型隐球菌、格特隐球菌和白色念珠菌感染期间的体外宿主转录组学
J Infect Dis. 2025 Feb 4;231(1):e254-e262. doi: 10.1093/infdis/jiae410.
3
Immunoprotection against Cryptococcosis Offered by Znf2 Depends on Capsule and the Hyphal Morphology.锌指蛋白 2 介导的免疫保护作用依赖于荚膜和菌丝形态。
mBio. 2022 Feb 22;13(1):e0278521. doi: 10.1128/mbio.02785-21. Epub 2022 Jan 11.
4
Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.鉴定与新型隐球菌性脑膜炎患者血清 IgG 反应的疾病相关隐球菌蛋白。
Front Immunol. 2021 Jul 23;12:709695. doi: 10.3389/fimmu.2021.709695. eCollection 2021.
5
Unique subsite specificity and potential natural function of a chitosan deacetylase from the human pathogen .来自人类病原体的壳聚糖脱乙酰酶的独特亚位特异性和潜在天然功能。
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3551-3559. doi: 10.1073/pnas.1915798117. Epub 2020 Feb 3.
6
An inherent T cell deficit in healthy males to C. neoformans infection may begin to explain the sex susceptibility in incidence of cryptococcosis.健康男性对新型隐球菌感染的固有 T 细胞缺陷可能开始解释隐球菌病发病中性别易感性的原因。
Biol Sex Differ. 2019 Sep 2;10(1):44. doi: 10.1186/s13293-019-0258-2.
7
Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination.鼻腔内接种新型隐球菌可导致小鼠鼻腔感染并迅速向脑部播散。
mSphere. 2019 Aug 7;4(4):e00483-19. doi: 10.1128/mSphere.00483-19.
8
Adaptive Immunity to Infections.对感染的适应性免疫
J Fungi (Basel). 2017;3(4). doi: 10.3390/jof3040064. Epub 2017 Nov 21.
9
Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.隐球菌病期间对新型隐球菌和格特隐球菌的免疫
Fungal Genet Biol. 2015 May;78:76-86. doi: 10.1016/j.fgb.2014.11.006. Epub 2014 Dec 12.
10
Microevolution during serial mouse passage demonstrates FRE3 as a virulence adaptation gene in Cryptococcus neoformans.连续传代小鼠过程中的微进化表明 FRE3 是新型隐球菌中的一个毒力适应基因。
mBio. 2014 Apr 1;5(2):e00941-14. doi: 10.1128/mBio.00941-14.

本文引用的文献

1
Cryptococcosis (torulosis). Current concepts and therapy.隐球菌病(芽生菌病)。当前概念与治疗方法
Am J Med. 1959 Dec;27:976-98. doi: 10.1016/0002-9343(59)90181-0.
2
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?抗体和/或细胞介导的免疫,真菌病中的保护机制:是一个持续存在的困境还是一场不必要的争论?
Med Mycol. 1998;36 Suppl 1:95-105.
3
Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents.人类致病真菌新生隐球菌的表型转换与啮齿动物的毒力变化和肺部炎症反应有关。
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14967-72. doi: 10.1073/pnas.95.25.14967.
4
Diversity of antigen recognition by serum antibodies in experimental bovine tuberculosis.实验性牛结核病中血清抗体对抗原识别的多样性
Infect Immun. 1998 Nov;66(11):5344-9. doi: 10.1128/IAI.66.11.5344-5349.1998.
5
Heterogeneous antibody responses in tuberculosis.结核病中的异质性抗体反应。
Infect Immun. 1998 Aug;66(8):3936-40. doi: 10.1128/IAI.66.8.3936-3940.1998.
6
Prospects for the development of fungal vaccines.真菌疫苗的发展前景。
Clin Microbiol Rev. 1997 Oct;10(4):585-96. doi: 10.1128/CMR.10.4.585.
7
A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis.新型隐球菌的一种77千道尔顿蛋白,属于热休克蛋白70家族成员,是在患有肺隐球菌病的小鼠血清中检测到的主要抗原。
Infect Immun. 1997 May;65(5):1653-8. doi: 10.1128/iai.65.5.1653-1658.1997.
8
Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody.一种人抗隐球菌葡糖醛酸木聚糖甘露聚糖抗体识别的肽表位。
Infect Immun. 1997 Apr;65(4):1158-64. doi: 10.1128/iai.65.4.1158-1164.1997.
9
Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii by immune human sera.免疫人血清对新型隐球菌新生变种和格特变种细胞质酵母抗原的识别。
FEMS Immunol Med Microbiol. 1997 Feb;17(2):111-9. doi: 10.1111/j.1574-695X.1997.tb01003.x.
10
Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi?新型隐球菌:抗真菌抗体免疫作用的范例?
Zentralbl Bakteriol. 1996 Aug;284(4):475-95. doi: 10.1016/s0934-8840(96)80001-6.